Top–Down Proteomics of Human Saliva, Analyzed with Logistic Regression and Machine Learning Methods, Reveal Molecular Signatures of Ovarian Cancer

Author:

Scebba Francesca1,Salvadori Stefano2ORCID,Cateni Silvia3,Mantellini Paola4,Carozzi Francesca4,Bisanzi Simonetta4,Sani Cristina4,Robotti Marzia5,Barravecchia Ivana6,Martella Francesca7,Colla Valentina3ORCID,Angeloni Debora156

Affiliation:

1. Health Science Interdisciplinary Center, Scuola Superiore Sant’Anna, Via G. Moruzzi, 1, 56124 Pisa, Italy

2. Institute of Clinical Physiology, National Research Council, Via G. Moruzzi, 1, 56124 Pisa, Italy

3. Center for Information and Communication Technologies for Complex Industrial Systems and Processes (ICT-COISP), Telecommunications, Computer Engineering, and Photonics Institute (TeCIP), Scuola Superiore Sant’Anna, Via G. Moruzzi, 1, 56124 Pisa, Italy

4. Istituto per lo Studio, la Prevenzione e la Rete Oncologica (ISPRO), Via Cosimo il Vecchio, 2, 50139 Firenze, Italy

5. Ph.D. School in Translational Medicine, Scuola Superiore Sant’Anna, Via G. Moruzzi, 1, 56124 Pisa, Italy

6. The Institute of Biorobotics, Scuola Superiore Sant’Anna, Via G. Moruzzi, 1, 56124 Pisa, Italy

7. Breast Unit and SOC Oncologia Medica Firenze—Dipartimento Oncologico, Azienda Usl Toscana Centro, Ospedale Santa Maria Annunziata, Via dell’Antella, 58, 50012 Firenze, Italy

Abstract

Ovarian cancer (OC) is the most lethal of all gynecological cancers. Due to vague symptoms, OC is mostly detected at advanced stages, with a 5-year survival rate (SR) of only 30%; diagnosis at stage I increases the 5-year SR to 90%, suggesting that early diagnosis is essential to cure OC. Currently, the clinical need for an early, reliable diagnostic test for OC screening remains unmet; indeed, screening is not even recommended for healthy women with no familial history of OC for fear of post-screening adverse events. Salivary diagnostics is considered a major resource for diagnostics of the future. In this work, we searched for OC biomarkers (BMs) by comparing saliva samples of patients with various stages of OC, breast cancer (BC) patients, and healthy subjects using an unbiased, high-throughput proteomics approach. We analyzed the results using both logistic regression (LR) and machine learning (ML) for pattern analysis and variable selection to highlight molecular signatures for OC and BC diagnosis and possibly re-classification. Here, we show that saliva is an informative test fluid for an unbiased proteomic search of candidate BMs for identifying OC patients. Although we were not able to fully exploit the potential of ML methods due to the small sample size of our study, LR and ML provided patterns of candidate BMs that are now available for further validation analysis in the relevant population and for biochemical identification.

Funder

Fondo per la promozione e lo sviluppo delle politiche del Programma nazionale per la ricerca (PNR) 2021

Fondazione Cassa di Risparmio di Firenze

Publisher

MDPI AG

Subject

Inorganic Chemistry,Organic Chemistry,Physical and Theoretical Chemistry,Computer Science Applications,Spectroscopy,Molecular Biology,General Medicine,Catalysis

Reference73 articles.

1. (2023, August 29). Ovarian Cancer—Cancer Stat Facts, Available online: https://seer.cancer.gov/statfacts/html/ovary.html.

2. Diagnostic and Prognostic Biomarkers in Ovarian Cancer and the Potential Roles of Cancer Stem Cells–An Updated Review;Muinao;Exp. Cell Res.,2018

3. Ovarian Carcinoma Subtypes Are Different Diseases: Implications for Biomarker Studies;Kalloger;PLoS Med.,2008

4. Ovarian Cancer Development and Metastasis;Lengyel;Am. J. Pathol.,2010

5. Holschneider, C.H., Berek, J.S., and Chair, V. (2000). Ovarian Cancer: Epidemiology, Biology, and Prognostic Factors, John Wiley & Sons, Inc.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3